I. Thrombus analysis for acute stroke care: • Thrombus
histological features and Imaging Correlation studies
between histological features and thrombus imaging for non-
invasive clot prediction of thrombus composition.33–35,38–40,47,87,98 • Thrombus histological features
and acute treatments. Correlation studies between
histological features and thrombolysis
administration34,40 or measures of mechanical
thrombectomy32–34,40,46,50,87,98 for
predicting recanalization feasibility, informing
pre-treatment decision-making and advising on the most
efficacious therapy for removing the arterial
occlusion. |
II. Thrombus analysis for secondary stroke prevention: •
Assessing thrombus origin. Thrombus composition analysis as
an additional diagnostic tool in the workup of stroke to
assess thrombus origin and aid in etiology definition, in
particular in cryptogenic stroke.34,38,39,43,45,49 Thrombus composition analysis
unveiling pathogenic feature: bacterial signatures,
endothelial cells, calcifications, vascular wall components,
valve embolisms.30,45,48,49,50,52,53,56 Correlation studies between
thrombus composition analysis, etiology and imaging to
predict thrombus stroke etiology even when the thrombus is
not extracted.100 • Assessing thrombus age. Thrombus analysis and
insight into the age of formation.22,39
|
III. Thrombus analysis for advancing acute stroke treatment:
thrombolysis and thrombectomy. • Emerging new thrombus
composition targets for addressing lytic therapies.
Evidence that thrombus composition deserves
tailored/personalized thrombolytic approaches: e.g.
targeting the von Willebrand factor or neutrophil
extracellular traps.22,23,36,76,77 •
Assessing thrombus structure to develop new thrombectomy
devices. Thrombus analysis and modelling of analogs to
optimize training and development of thrombectomy devices
and technique.83–85,89,101
|